A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn… - The Journal of …, 2020 - Wiley Online Library
This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn… - JOURNAL OF …, 2020 - scholarworks.bwise.kr
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

[HTML][HTML] A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with …

W Kim, K Chang, EJ Cho, JC Ahn, CW Yu… - The Journal of …, 2020 - ncbi.nlm.nih.gov
This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn, CW Yu… - Journal of Clinical …, 2020 - pure.korea.ac.kr
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn, CW Yu… - Journal of Clinical …, 2020 - europepmc.org
This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn, CW Yu, KI Cho… - 2020 - ir.ymlib.yonsei.ac.kr
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn… - JOURNAL OF …, 2019 - repository.hanyang.ac.kr
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and …

W Kim, K Chang, EJ Cho, JC Ahn… - Journal of Clinical …, 2020 - cuk.elsevierpure.com
This multicenter, randomized, double-blind, parallel-group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …